| The Rider is Back on the MCLN Horse, But Will It Run? | | Print | |
| Written by Staff and Wire Reports | |||||||||||||||||||||||||||||||||||||
| Thursday, 03 December 2009 02:29 | |||||||||||||||||||||||||||||||||||||
 The incredible ride on our undervalued pick of the week, MedClean Technologies (OTC:MCLN) continues and to say that this one has been filled with theatrics, tragedy and tension is an understatement.
Here is a re-cap of the action thus far: On Sunday, we alerted our subscribers about a stock that we continue to feel has incredible potential for great returns. On Monday morning the same stock- which had been rising dramatically on a parabolic run from sub-penny levels gapped up and ran as high as $.075 before a tremendous wave of selling hit the shares. Yes, this type of profit taking can be seen at the end of several sessions during a parabolic run, but something smelled rotten even then. Frankly, it caught most everyone by complete surprise. "Parabolic runs occur in stocks that exhibit extreme behavior to the upside which is unsustainable," explains John Netto, author of the book One Shot One Kill Trading. "These stocks take off for a number of reasons but they can leave investors holding the bag after they retrace a large portion of their gains. A parabolic run depicts greed at its finest, with buyers tripping over one another trying to get long." The reason people were tripping to buy was obvious, this is a clearly undervalued stock in a sector where companies trade based on 14-25x earnings (not 3-4x earnings like most other stocks). Still, even the most bullish stock has to breathe on the way up. This was the second, multi-session, parabolic run for MedClean and the stage is set for another run to take place. At the end of these parabolic runs, people take profits and the stock can re-trace 50-62% or more. One can easily argue that this is a textbook example of what happened here, but the jury was still out as far as some were concerned. After all, rumors began to circulate that insiders had begun selling hard against the incredible volume and visibility that our readers brought to the stock. We immediately called the company and they vehemently denied that anyone on the management team was selling. This particular company is managed by an extremely serious, dedicated and experienced team that had taken at least one other company and matured it to over a billion dollar market cap. That was one of the main reasons we liked the stock to begin with. Why would they do this to their new company now? It just didn't make sense. Despite the rumors, interest and volume in the stock continued to rise, but for the following two sessions, every eager new buyer was still being met with a seller. Were the market makers who are still short the stock playing games? The float just kept churning, even as the enthusiasm and excitement continued to show up every morning for trading. At the crack of dawn on Wednesday, traders were met with a story that we had chased over night.
That was a very important development and when our Anti-Trust Medical Waste Story hit the news wires, shares of the smaller emerging competitors in the sector like MedClean itself and BioMedical Technology Solutions (BMTL.OB) were taken over by the bulls and they never looked back. Even on a down market day, both stocks closed at their respective highs at the end of the day. Very bullish. Almost immediately, another wave of rumors hit the street. Ugly rumors. Rumors that threatened to make this entire play look like the biggest pump and dump scheme our readers had seen in a long time. We had to chase down and confront those rumors with facts. BiomedReport's Len Berner helped uncover a filing that unmasked the silent seller which had crashed our pick's party on Monday. According to the mandated filing, Manatuck Hill Partners, LLC had been dumping shares and warrants from their MCLN portfolio into the market. All the way down, in fact, the shares were just being disposed of with little regard to lower and lower prices. Manatuck had been a huge holder in the company and at one point even appeared to pick up more shares- a sign that early investors had hung their hat on as yet another reason to buy-in to this hidden gem. Was this a terribly bad sign? A horrible omen? Why sell now when logic would seem to indicate that prices are set to rise higher given the attention, volume and healthy consolidation we had just seen? "Manatuck was the spin-off of the Pequot Scout Fund," explained Scott Grisanti, Chairman of the Board at MCLN. "Pequot as you may know radically transformed their operations, not quite a shut down or liquidation, but close to it." Indeed, according to an article from HedgeTracker dated May 29 of this year, the investment team that managed Pequot Capital Management’s small-cap focused Pequot Scout Fund spun off from the troubled firm to create Manatuck Hill Partners. The new firm was supposed to continue to manage the Scout Fund, but as some insiders explained: "What we may be seeing here is Pequot catching up on paperwork, closing out accounts or simply ridding themselves of assets." "The spin off, ten person team that planned and formed Manatuck had gone on record and said that they wanted to be independent from Pequot on July 1, but share prices and warrants may not have been exercisable until now. Their investment/financing decisions could be little more than an unemotional shuffling of paper, and that certainly seems to be the most logical explanation. Especially given the subsiding number of sales. It appears the group has divested itself of all the shares/warrants it can for now. That's not to say that there may still be some restricted shares or warrants that exist, but those do not appear to be exercisable any time soon from what we can see." Given the way the bulls took over the stock at one particular point in time during the day on Wednesday, it certainly looks like that vicious selling may finally be over. As one trader put it, "The rider is back on the MCLN horse." But will the horse now continue to run? Our technical analysis chart certainly indicates like it might. In fact, if the stock can break some minimal resistance at $.04, traders could get confirmation of yet another break-out run. Who said investing in this sector was boring?  Please be patient and look for the second part of our three part special on MCLN here tomorrow. A very lengthy interview with the management team at MCLN was originally set to be fully transcribed and released here by now. In fact, we had hoped to bring you at least part of that transcribed interview today, but as you can see- we were sent on yet another chase trying to track down the facts presented herein. We hope it was worth the wait. Giddy up! BiomedReports is not paid or compensated to report news and developments about publicly traded companies. Full disclosure can be read at the bottom of / About Us / Section Add this page to your favorite Social Bookmarking websites           
Set as favorite
Bookmark
Email this
Trackback(0)
Comments (11)
David Gunning
said:
|
TrackBack URI for this entry
Subscribe to this comment's feed|
... Manatuck, itself, is a relic left over from an era of excessive greed. Although it is likely they were simply relieving themselves of an extremely risky position in MCLN, they still have a substantial position. If this company grows a strong pair of legs, Manatuck will find themselves holding on to a gold mine they won't soon let go of. |
|
santosh Subramaniam
said:
|
... Why didn't Mantuck Partners sell any interest in MCLN on the 30th, when the prices were high ?. Why wait until 1st or 2nd and get a bad price ?. |
|
Ray Buccino
said:
|
... I have another concern about MCLN. A large part of their success would depend on the contract with MedAssests. A visit to the MedAsset web site shows no mention of a relationship to MCLN. Even an advanced search of the site does not show any results for either MCLN or a more generic regulated waste disposal. I do not see how MCLN will benefit from a relationship with MedAssets if MedAssets does not promote the relationship in any way. |
|
Robert
said:
|
... I must give credit where credit is due. I never thought MCLN would get back to .04, much less break it. Grats BMR! (To try and make up for my doubt... VVUS has shown some nice action over the past three days. Three Rising Soldiers candle pattern on increasing volume. A Friday increase in volume if substantial may mean something for Monday, or not. In my wildest fantasy I would be hoping for a buy out announcement... but it probably means nothing more than a position being taken :) |
|
Matt D.
said:
|
... It would explain some of the crazy selling and pps action, but it appears to have stabilized for now. Is MCLN all hype and speculative right now or are there legit short term news or catalysts to look forward to??? Thats the question. I am currently holding my position, adding on any big dips. |
|
David Gunning
said:
|
... According to their SEC filing, Manatuck has exercised all of their current warrants, not to say their isn't more in the future. This held up nicely, even with large blocks of selling action. The reason they sold Monday says a lot. It takes time to file the appropriate paper work with the SEC. Manatuck is simply shoring up their books, as apposed to worry about getting the best sale price. Look for a nice continued consolidation period tomorrow. If we finish well into the 4's this thing is set for a substantial, and sustainable move up in the next few weeks. |
|
Fletcher Davis
said:
|
... According to what I see on their Schedule 13D/A filing, they (Mantuck) have 135 million shares as of 11/9 and over the last few days have sold ~60 million including over 10 million yesterday (most recent filing). |
|
carl disotell
said:
|
... Is this part of the "Manatuck" spin-off? Not sure yet what is going on? Q What is the float ? MedClean Technologies Announces Results Of Private Exchange Offer - Quick Facts (RTTNews) - Wednesday, MedClean Technologies Inc. (MCLN.OB) announced results of its private offer to exchange all of its existing Common Stock Purchase Warrants with Initial Exercise Dates between July 11, 2008 and August 29, 2008. The exchange is for newly issued Common Stock Purchase Warrants with a new lower exercise price of $0.0075 per share, exercisable for one-half the original number of shares of its common stock, par value $0.0001 per share and without a cashless exercise right. The company noted that as of the expiration time, it received Existing Warrants for exchange representing 334.8 million shares of common stock, a 92% success rate for the offer to exchange. MedClean Technologies Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. For comments and feedback: contact editorial@rttnews.com |
|
carl disotell
said:
|
... Why is there no message board on Yahoo? Who is screening these "posts" ? Please post criteria for vetting this board, only interested in confirming all "points of view" are being offered? CD |
|
Write comment
